Windlas Biotech schedules virtual group investor meeting on April 20, 2026 at 3:00 PM.
Meeting conducted under SEBI Listing Regulations compliance requirement Reg. 30(6).
Company confirms no unpublished price sensitive information will be shared during discussions.